Cargando…
MicroRNAs and Triple Negative Breast Cancer
Triple Negative Breast Cancer (TNBC) is a very aggressive tumor subtype, which still lacks specific markers for an effective targeted therapy. Despite the common feature of negativity for the three most relevant receptors (ER, PgR and HER2), TNBC is a very heterogeneous disease where different subgr...
Autores principales: | D’Ippolito, Elvira, Iorio, Marilena V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856060/ https://www.ncbi.nlm.nih.gov/pubmed/24284394 http://dx.doi.org/10.3390/ijms141122202 |
Ejemplares similares
-
MicroRNAs in regulation of triple-negative breast cancer progression
por: Piasecka, Dominika, et al.
Publicado: (2018) -
The Therapeutic Potential of MicroRNAs in Cancer: Illusion or Opportunity?
por: Fortunato, Orazio, et al.
Publicado: (2020) -
Circulating microRNAs and their role in the immune response in triple-negative breast cancer
por: Piña-Sánchez, Patricia, et al.
Publicado: (2020) -
Modulatory Role of microRNAs in Triple Negative Breast Cancer with Basal-Like Phenotype
por: Angius, Andrea, et al.
Publicado: (2020) -
Regulation of Inflammasome by microRNAs in Triple-Negative Breast Cancer: New Opportunities for Therapy
por: (Stămat), Liliana-Roxana Balahura, et al.
Publicado: (2023)